Description

Rizendros 35 (Risedronic Acid) Coated Tablets 35 mg.

Rizendros 35 is a medication that comes in the form of coated tablets containing 35 mg. of Risedronic Acid. It is commonly prescribed for the treatment of conditions such as osteoporosis, Paget’s disease of the bone, and other bone-related disorders. This medication belongs to a class of drugs known as bisphosphonates, which work by slowing down the breakdown of bone tissue, thereby helping to increase bone density and strength.

Indications

Rizendros 35 is primarily used to treat osteoporosis in postmenopausal women and men at increased risk of fractures. Osteoporosis is a condition characterized by weakened and brittle bones, making them more susceptible to fractures. Rizendros 35 helps to reduce the risk of fractures and improve bone health in individuals with osteoporosis.

In addition to osteoporosis, Rizendros 35 may also be prescribed for the treatment of Paget’s disease of the bone, a chronic disorder that causes abnormal bone growth and remodeling. By inhibiting bone resorption, Rizendros 35 can help to regulate bone turnover and alleviate the symptoms associated with Paget’s disease.

Mechanism of Action

Risedronic Acid, the active ingredient in Rizendros 35, works by inhibiting osteoclast-mediated bone resorption. Osteoclasts are cells responsible for breaking down bone tissue, a process known as bone resorption. By inhibiting the activity of these cells, Risedronic Acid helps to maintain bone density and prevent bone loss.

Furthermore, Risedronic Acid has been shown to promote the formation of new bone tissue by stimulating osteoblast activity. Osteoblasts are cells that are responsible for building new bone tissue, thereby contributing to bone remodeling and strengthening.

Dosage and Administration

Rizendros 35 tablets should be taken orally, preferably on an empty stomach at least 30 minutes before the first food or drink of the day. The tablet should be swallowed whole with a full glass of water to ensure proper absorption and minimize the risk of irritation to the esophagus.

The recommended dosage of Rizendros 35 for the treatment of osteoporosis is one 35 mg. tablet once a week. It is important to follow the dosing schedule prescribed by your healthcare provider and not exceed the recommended dose to avoid potential side effects.

If you miss a dose of Rizendros 35, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

Side Effects

Like all medications, Rizendros 35 may cause side effects in some individuals. Common side effects of Rizendros 35 may include:

• Stomach pain or discomfort
• Nausea or vomiting
• Diarrhea or constipation
• Headache
• Muscle or joint pain

If you experience any severe or persistent side effects while taking Rizendros 35, contact your healthcare provider immediately. In rare cases, Rizendros 35 may cause more serious side effects such as osteonecrosis of the jaw or atypical fractures of the femur. These side effects require prompt medical attention.

Precautions

Before taking Rizendros 35, inform your healthcare provider about any medical conditions you have, especially kidney problems, low blood calcium levels, or difficulty swallowing. It is important to disclose all medications you are currently taking, including over-the-counter drugs, supplements, and herbal products, as they may interact with Rizendros 35.

It is essential to follow the instructions provided by your healthcare provider regarding the use of Rizendros 35, including dosing, administration, and potential drug interactions. Do not stop taking Rizendros 35 abruptly without consulting your healthcare provider, as this may lead to a rebound effect and worsen your condition.

Storage

Store Rizendros 35 tablets in a cool, dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets to prevent accidental ingestion. Do not use Rizendros 35 past the expiration date printed on the packaging.

Conclusion

Rizendros 35 is a medication commonly prescribed for the treatment of osteoporosis and other bone-related disorders. By inhibiting bone resorption and promoting bone formation, Rizendros 35 helps to improve bone density and reduce the risk of fractures in individuals with osteoporosis.

It is important to take Rizendros 35 as directed by your healthcare provider and to report any side effects or concerns promptly. By following the prescribed dosing schedule and precautions, you can effectively manage your condition and improve your bone health with the help of Rizendros 35.